S
Sunita
About Sunita
Data last updated:
Sunita is a Director at Biophar Lifesciences Private Limited (since 2023) and Director at Rechelist Pharma Private Limited (since 2025). The companies operate in Pharma. The largest current company by reported revenue is Biophar Lifesciences Private Limited at ₹21.73 Cr (FY 2024). Earlier, Sunita was a Director at Lewis Bioserch Pharma Private Limited (2012–2023) and Director at Angiolife Healthcare Private Limited (2012–2023) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biophar Lifesciences Private Limited U24132CH2010PTC032343 | Director | 21 Jan 2023 | 2010 | ₹21.73 Cr (FY 2024) | Active |
 Rechelist Pharma Private Limited U47721PB2024PTC062947 | Director | 06 Feb 2025 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Lewis Bioserch Pharma Private Limited U24100CH2012PTC033656 | Director | 22 Mar 2012 | 2012 | ₹4.94 Cr (FY 2024) | Active |
 Angiolife Healthcare Private Limited U24100CH2012PTC033818 | Director | 22 May 2012 | 2012 | ₹11.23 Cr (FY 2024) | Active |
 Abibba Pharmaa Private Limited U24232CH2014PTC034927 | Director | 16 Jan 2014 | 2014 | ₹4.24 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sunita
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gulshan Rawat | 03064105 | Biophar Lifesciences Private Limited , Rechelist Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunita
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunita
Sunita currently holds 2 directorships: Biophar Lifesciences Private Limited (Director, since 21 Jan 2023, revenue ₹21.73 Cr (FY 2024)); Rechelist Pharma Private Limited (Director, since 06 Feb 2025).
Sunita was first appointed on 22 Mar 2012 as Director at Lewis Bioserch Pharma Private Limited. The most recent appointment on record is 06 Feb 2025 at Rechelist Pharma Private Limited.
Sunita held 3 earlier board appointments: Lewis Bioserch Pharma Private Limited (Director, 22 Mar 2012 to 20 Jan 2023); Angiolife Healthcare Private Limited (Director, 22 May 2012 to 20 Jan 2023); Abibba Pharmaa Private Limited (Director, 16 Jan 2014 to 11 Sep 2015).
The current boards of Sunita's companies include Gulshan Rawat (Biophar Lifesciences Private Limited).